Screener
The Cooper Companies, Inc. COO CooperSurgical — Research and development expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Cooper Companies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026.
- Filed
- Jun 5, 2026, 4:47 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-041305
| (In millions) / Three Months Ended April 30, 2026 | Cooper Vision | Cooper Surgical | Corporate (1) | Consolidated |
|---|---|---|---|---|
| Net sales | $723.5 | $358.0 | — | $1,081.5 |
| Cost of sales | 229.4 | 116.7 | — | 346.1 |
| Selling, general and administrative expense | 252.2 | 402.4 | 21.6 | 676.2 |
| Research and development expense | 22.1 | 20.4 | — | 42.5 |
| Amortization expense | 4.2 | 43.5 | — | 47.7 |
| Operating income (loss) | $215.6 | $(225.0) | $(21.6) | $(31.0) |
| Interest expense | 20.9 | |||
| Other (income) expense, net | (3.5) |
Item 1. Unaudited Financial Statements
FAQ
- What is The Cooper Companies, Inc.'s coopersurgical — research and development expense?
- The Cooper Companies, Inc. (COO) reported coopersurgical — research and development expense of $20.4M in Q1 2026.
- How has The Cooper Companies, Inc.'s coopersurgical — research and development expense changed year-over-year?
- The Cooper Companies, Inc.'s coopersurgical — research and development expense increased by 2.5% year-over-year, from $19.9M to $20.4M.
- What does coopersurgical — research and development expense mean?
- Costs incurred for the research, design, and clinical development of new surgical products and technologies. This investment is critical for maintaining a competitive pipeline in the medical device market.
Ask your AI about The Cooper Companies, Inc.'s coopersurgical — research and development expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude